Endocrinology, Vol 125, 971-975, Copyright © 1989 by Endocrine Society

ARTICLES

In vivo hypothalamic release of thyrotropin-releasing hormone after electrical stimulation of the paraventricular area: comparison between push-pull perfusion technique and collection of hypophysial portal blood

JM Rondeel, WJ de Greef, PD van der Vaart, P van der Schoot and TJ Visser
Department of Endocrinology, Erasmus University, Rotterdam, The Netherlands.

Unilateral electrical stimulation for 15 min of the paraventricular area of anesthetized rats induced a 2- to 3- fold increase in plasma TSH levels and caused an increased release of TRH into hypophysial stalk blood from 217 +/- 25 to 530 +/- 90 pg/15 min (n = 6). This experimental model was then used to determine the in vivo hypothalamic release of TRH by push-pull perfusion of either the mediobasal hypothalamus (MBH) or anterior pituitary (AP). Before stimulation, TRH release per 15 min was 4.2 +/- 0.7 pg from the MBH (n = 18) and 3.5 +/- 0.3 pg from the AP (n = 13). Unilateral electrical stimulation of the paraventricular area led to higher plasma TSH levels in 27 of 31 rats, and levels during stimulation increased from 0.89 +/- 0.04 to 1.86 +/- 0.10 ng/ml (n = 31). No significant increase in TRH in the perfusates was observed when push-pull perfusion was done in the MBH contralateral to the site of stimulation (n = 6). However, TRH release increased 2- to 3-fold during the perfusion of the MBH ipsilateral to the site of stimulation (15.4 +/- 4.3 pg/15 min; n = 13). In conclusion, push-pull perfusion of the MBH or AP can be used to estimate hypothalamic TRH release. However, the output of TRH by push-pull perfusion is low and varies considerably between individual rats. Thus, the practical value of push-pull perfusion for measurement of in vivo TRH release seems limited.

This article has been cited by other articles:

				M. Yamada, N. Shibusawa, S. Ishii, K. Horiguchi, R. Umezawa, K. Hashimoto, T. Monden, T. Satoh, J. Hirato, and M. Mori Prolactin Secretion in Mice with Thyrotropin-Releasing Hormone Deficiency Endocrinology, May 1, 2006; 147(5): 2591 - 2596. [Abstract] [Full Text] [PDF]

				E. Jing, E. A. Nillni, V. C. Sanchez, R. C. Stuart, and D. J. Good Deletion of the Nhlh2 Transcription Factor Decreases the Levels of the Anorexigenic Peptides {alpha} Melanocyte-Stimulating Hormone and Thyrotropin-Releasing Hormone and Implicates Prohormone Convertases I and II in Obesity Endocrinology, April 1, 2004; 145(4): 1503 - 1513. [Abstract] [Full Text] [PDF]